Singapore markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
109.45+3.24 (+3.05%)
At close: 04:06PM EDT
109.00 -0.45 (-0.41%)
After hours: 07:56PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close106.21
Bid108.80 x 800
Ask109.60 x 1200
Day's range106.44 - 109.62
52-week range101.24 - 142.60
Avg. volume5,511,564
Market cap191.64B
Beta (5Y monthly)0.72
PE ratio (TTM)25.41
EPS (TTM)4.31
Earnings date20 Jul 2022 - 25 Jul 2022
Forward dividend & yield1.88 (1.83%)
Ex-dividend date14 Jul 2022
1y target est139.29
  • Zacks

    Abbott (ABT) Gains But Lags Market: What You Should Know

    In the latest trading session, Abbott (ABT) closed at $106.21, marking a +0.73% move from the previous day.

  • Yahoo Finance Video

    FDA probes 5th infant illness tied to Abbott formula, former Nikola CEO charged with wire fraud

    Notable business headlines include the FDA investigating the death of an infant who consumed formula by Abbott Laboratories, Tesla CEO Elon Musk calling his factories “gigantic money furnaces” as firestorms surround the company, and former Nikola Motors CEO Trevor Milton being charged with wire fraud.

  • Motley Fool

    5 Dividend Kings to Buy Now

    For dividend growth investors the market drop hasn't been as severe and they can sleep better at night knowing that their passive income will almost certainly grow, regardless of what happens in the market. This is especially true for those who are invested in dividend growth stocks that have earned the title Dividend King. If you are seeking to grow your passive income and wealth over the long haul, you might want to take a closer look at any of these five Dividend Kings that look like great buys at the moment.